Andrew Perry
Corporate Officer/Principal presso G1 THERAPEUTICS, INC.
Patrimonio netto: 256 760 $ in data 30/06/2024
Profilo
Andrew Perry is currently the Chief Commercial Officer at G1 Therapeutics, Inc. He previously worked as the Vice President of US Marketing at ViiV Healthcare Ltd.
Mr. Perry is a graduate of the University of Glasgow and The University of Sheffield.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0.22% | 05/07/2024 | 112 614 ( 0.22% ) | 256 760 $ | 30/06/2024 |
Posizioni attive di Andrew Perry
| Società | Posizione | Inizio |
|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2021 |
Precedenti posizioni note di Andrew Perry
| Società | Posizione | Fine |
|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Andrew Perry
| University of Glasgow | Graduate Degree |
| The University of Sheffield | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Andrew Perry
